Leiner first quarter sales rise 33.2% to $94.1 mil.; recapitalization results in loss.
This article was originally published in The Tan Sheet
Executive Summary
LEINER SALES RISE 33.2% TO $94.1 MIL. IN FIRST QUARTER ended June 30, Leiner Health Products announced Sept. 2. Sales for the quarter were boosted by the recently acquired Vita Health company and higher revenues for both vitamins and OTC drugs. Operating income, excluding expenses related to the company's recent recapitalization, increased 76.8% to $4.2 mil. However, as a result of the recapitalization expenses, the company recorded an operating loss of $16.4 mil. for the quarter.